ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test
Welcome to DNA Labs UAE, where we offer the ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test. This test is designed to diagnose and provide valuable information about the rare genetic disorder known as hyaline fibromatosis syndrome.
Test Components and Price
The ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes or the entire genome.
Test Type and Doctor
The ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test falls under the categories of Osteology, Dermatology, and Immunology Disorders. It is recommended to consult with a dermatologist for this test.
Test Department and Pre Test Information
The test is conducted in our Genetics department. Prior to the test, it is essential to provide the clinical history of the patient who will undergo the ANTXR2 Gene Hyaline Fibromatosis Syndrome NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the ANTXR2 Gene.
Test Details
The ANTXR2 gene is associated with hyaline fibromatosis syndrome, a rare genetic disorder characterized by the abnormal accumulation of hyaline in various tissues and organs of the body. NGS genetic testing allows for the identification of mutations or variations in the ANTXR2 gene that may be responsible for causing the disorder.
To conduct the test, a sample of DNA is collected through a blood sample or a cheek swab. The DNA is then sequenced using advanced sequencing technologies to identify any mutations or variations in the ANTXR2 gene.
Results and Implications
The results of the NGS genetic test confirm the diagnosis of hyaline fibromatosis syndrome and provide information about the specific genetic mutation or variation present. This information is crucial for determining the prognosis, inheritance pattern, and potential treatment options for individuals affected by this disorder.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to schedule your ANTXR2 Gene Hyaline Fibromatosis Syndrome Genetic Test.
Test Name | ANTXR2 Gene Hyaline fibromatosis syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ANTXR2 Gene Hyaline fibromatosis syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANTXR2 Gene Hyaline fibromatosis syndrome NGS Genetic DNA Test gene ANTXR2 |
Test Details |
The ANTXR2 gene is associated with a rare genetic disorder called hyaline fibromatosis syndrome. This syndrome is characterized by the abnormal accumulation of a substance called hyaline in various tissues and organs of the body. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of hyaline fibromatosis syndrome, NGS genetic testing can be used to identify mutations or variations in the ANTXR2 gene that may be responsible for causing the disorder. NGS genetic testing for hyaline fibromatosis syndrome involves collecting a sample of DNA, usually through a blood sample or a cheek swab. The DNA is then sequenced using advanced sequencing technologies to identify any mutations or variations in the ANTXR2 gene. The results of the NGS genetic test can help confirm a diagnosis of hyaline fibromatosis syndrome and provide information about the specific genetic mutation or variation present. This information can be useful for determining the prognosis, inheritance pattern, and potential treatment options for individuals affected by this disorder. |